NagashreeSeetharamuMD
Oncology • New Hyde Park, NYAssistant Professor, Medicine, New York University School of Medicine
Dr. Seetharamu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
27005 76th Ave
New Hyde Park, NY 11040Phone+1 917-574-8494Fax+1 516-734-8950
Education & Training
NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2006 - 2009- NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2006 - 2007
Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 2003 - 2006
Government Medical College VijayanagarClass of 1996
Certifications & Licensure
NY State Medical License 2006 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jun 01
- Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2013 Oct 14
Publications & Presentations
PubMed
- Clinical predictors of premature radiotherapy terminations in senior adults with oral cavity and laryngeal carcinoma.Dylan J Cooper, Isabella Travaglia, Meytal Guller, Wesley J Talcott, Maged Ghaly
Head & Neck. 2024-02-01 - 3 citationsRates of Occult Invasive Disease in Patients With Biopsy-Proven Oral Cavity Squamous Cell Carcinoma in Situ.Dylan J Cooper, Yonah Ziemba, Lucio Pereira, Benjamin H Kann, Bhupesh Parashar
JAMA Otolaryngology-- Head & Neck Surgery. 2024-02-01 - Proteasome inhibition paradoxically degrades gain-of-function mutant p53 R273H in NSCLC and could have therapeutic implications.Eziafa I Oduah, Susan T Sharfstein, Nagashree Seetharamu, Steven R Grossman, Larisa Litovchick
Frontiers in Oncology. 2024-01-01
Journal Articles
- Caring for Patients with Cancer in the Face of Self-Vulnerability During the COVID-19 Pandemic—ReplyNagashree Seetharamu, MD, JAMA Oncology
Authored Content
- Caring for Patients with Cancer in the Face of Self-Vulnerability During the COVID-19 Pandemic—ReplyAugust 2020
Press Mentions
Many with Advanced Lung Cancer Don't Get Treatments That Might HelpJanuary 21st, 2017
Lung Cancer Pill Halves Risk of Death in Some PeopleJune 9th, 2023- Lung Cancer Pill Halves Risk of Death in Some PeopleOctober 5th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
